Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE,a randomized controlled trial期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE,a randomized controlled trial

Authors:	Alice Gottlieb John Sullivan Martijn van Doorn Alexey Kubanov Ruquan You Anne Parneix Sophie Hugot Marina Milutinovic

Affiliation:	1. Department of Dermatology, New York Medical College, Valhalla, New York;2. Holdsworth House Medical Practice, Darlinghurst, Australia;3. Erasmus MC, Rotterdam, The Netherlands;4. State Scientific Center of Dermatology, Venereology and Cosmetology, Moscow, Russia;5. Beijing Novartis Pharma Co. Ltd, Shanghai, China;6. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey;g. Novartis Pharma AG, Basel, Switzerland

Abstract:

Keywords:	palmoplantar psoriasis clear or almost clear skin clinical trial secukinumab superiority quality of life AE adverse event BSA body surface area DLQI Dermatology Life Quality Index EQ-5D Euro Quality-of-Life 5-Dimension Health Status Questionnaire HRQoL health-related quality of life IGA Investigator's Global Assessment IgG immunoglobulin G IL interleukin PASI Psoriasis Area and Severity Index ppIGA Palmoplantar Investigator's Global Assessment ppPASI Palmoplantar Psoriasis Area and Severity Index ppPGA Palmoplantar Physician Global Assessment ppQLI Palmoplantar Quality-of-Life Instrument QoL quality of life SAE serious adverse event SGA Subject Global Assessment
本文献已被 ScienceDirect 等数据库收录！